MX2013010831A - Metodo para mejorar la salud osea en los bebes usando los acidos grasos poliinsaturados de cadena larga. - Google Patents

Metodo para mejorar la salud osea en los bebes usando los acidos grasos poliinsaturados de cadena larga.

Info

Publication number
MX2013010831A
MX2013010831A MX2013010831A MX2013010831A MX2013010831A MX 2013010831 A MX2013010831 A MX 2013010831A MX 2013010831 A MX2013010831 A MX 2013010831A MX 2013010831 A MX2013010831 A MX 2013010831A MX 2013010831 A MX2013010831 A MX 2013010831A
Authority
MX
Mexico
Prior art keywords
methods
bone health
infants
fatty acids
long chain
Prior art date
Application number
MX2013010831A
Other languages
English (en)
Inventor
Jose Maria Lopez Pedrosa
Manuel Manzano Martin
Ricardo Rueda Cabrera
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX2013010831A publication Critical patent/MX2013010831A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • A23L33/155Vitamins A or D
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30Dietetic or nutritional methods, e.g. for losing weight
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Se describen los métodos para mejorar la salud, la resistencia y la formación óseas en un bebé que puede ser susceptible a los problemas de la salud ósea que se desarrollan desde la procreación hasta la adolescencia. Los métodos incluyen administrar una formulación nutricional que incluye por lo menos un LCPUFA a una mujer durante el embarazo y opcionalmente durante la lactancia y el amamantamiento de un bebé.
MX2013010831A 2011-03-21 2012-03-20 Metodo para mejorar la salud osea en los bebes usando los acidos grasos poliinsaturados de cadena larga. MX2013010831A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11380021A EP2502506A1 (en) 2011-03-21 2011-03-21 Methods for improving bone health in infants using long chain polyunsaturated fatty acids
PCT/US2012/029796 WO2012129222A1 (en) 2011-03-21 2012-03-20 Methods for improving bone health in infants using long chain polyunsaturated fatty acids

Publications (1)

Publication Number Publication Date
MX2013010831A true MX2013010831A (es) 2013-11-18

Family

ID=44343642

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013010831A MX2013010831A (es) 2011-03-21 2012-03-20 Metodo para mejorar la salud osea en los bebes usando los acidos grasos poliinsaturados de cadena larga.

Country Status (8)

Country Link
US (1) US20120245121A1 (es)
EP (1) EP2502506A1 (es)
CN (1) CN103533853A (es)
BR (1) BR112013024189A2 (es)
CA (1) CA2829794A1 (es)
IL (1) IL228339A0 (es)
MX (1) MX2013010831A (es)
WO (1) WO2012129222A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ720946A (en) 2009-04-29 2017-09-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
MX2011011538A (es) 2009-04-29 2012-06-13 Amarin Pharma Inc Composicion farmaceutica estable y metodos de uso de la misma.
SI3318255T1 (sl) 2009-06-15 2021-07-30 Amarin Pharmaceuticals Ireland Limited Kompozicije in metode za zdravljenje kapi pri subjektu, ki prejema sočasno zdravljenje s statinom
CA2775339C (en) 2009-09-23 2017-03-28 Amarin Corporation Plc Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
AU2011336856A1 (en) 2010-11-29 2013-07-04 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
EP2745706A1 (en) * 2012-12-24 2014-06-25 Abbott Laboratories, Inc. Methods for maintaining bone quality
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
PL225614B1 (pl) 2013-10-08 2017-04-28 Zachodniopomorski Univ Tech W Szczecinie Prozdrowotny produkt spożywczy
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
MA51766A (fr) 2018-09-24 2020-12-16 Amarin Pharmaceuticals Ie Ltd Procédés de réduction du risque d'événements cardiovasculaires chez un sujet
KR20240012390A (ko) 2021-04-21 2024-01-29 애머린 파마슈티칼스 아일랜드 리미티드 심부전의 위험을 감소시키는 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2623214C (en) * 2005-09-30 2011-07-26 Hill's Pet Nutrition, Inc. Methods for extending the shelf-life of food compositions containing polyunsaturated fatty acids
US20080076823A1 (en) * 2006-08-09 2008-03-27 Watkins Bruce A Methods of improving bone health and muscle health
CN101433240B (zh) * 2007-11-16 2013-01-16 光明乳业股份有限公司 一种适合孕妇和乳母食用的牛奶及其制备方法

Also Published As

Publication number Publication date
US20120245121A1 (en) 2012-09-27
BR112013024189A2 (pt) 2016-12-13
CA2829794A1 (en) 2012-09-27
EP2502506A1 (en) 2012-09-26
CN103533853A (zh) 2014-01-22
IL228339A0 (en) 2013-12-31
WO2012129222A1 (en) 2012-09-27

Similar Documents

Publication Publication Date Title
MX2013010831A (es) Metodo para mejorar la salud osea en los bebes usando los acidos grasos poliinsaturados de cadena larga.
MX2013010830A (es) Metodos para mejorar la salud osea en los bebes usando los prebioticos.
EA201201281A1 (ru) Обогащение диеты матерей сиаловой кислотой
MY186188A (en) Nutritional phytonutrient compositions
NZ613165A (en) Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated fatty acids and uses thereof
MY166016A (en) Infant nutrition for improving fatty acid composition of brain membranes
MY191538A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
PH12019550208A1 (en) Hmos blends for use in infants or young children for health purposes
PH12018500090A1 (en) Nutritional compositions and methods for promoting cognitive development
MX350870B (es) Formula para lactantes con alto palmitato sn-2 y oligofructosa.
PL2398527T3 (pl) Sposób do zastosowania z odciągaczem pokarmu w celu zapoczątkowania wypływu mleka przy karmieniu piersią, w szczególności dla wcześniaków
PH12018500035A1 (en) Nutritional compositions and methods for promoting cognitive development
PH12016501952A1 (en) Nutritional compositions directed to subjects having cow`s milk protein allergies
MY175195A (en) Nutritional compositions
PH12016500763A1 (en) Synthetic milk compositions comprising polyunsaturated fatty acids (pufas) for promoting the healthy establishment of cognitive function in male and female infant and children
PH12015502517B1 (en) Compositions and methods for nutrient delivery
NZ604981A (en) Early programming of brain function through soy protein feeding
PH12015500683A1 (en) Formula fortifier
PH12015502054A1 (en) Prenatal and lactation supplements to enhance central nervous system development of offspring
MY169302A (en) Compositions and methods for nutrient delivery
RU2016143827A (ru) Дифференцированные по полу искусственные питательные композиции и содержащие их системы питания
PH22015000587Y1 (en) A formulation for female breast and buttocks enhancement
임지나 et al. Longitudinal study of iron concentration in Korean preterm human milk
UA69863U (ru) Способ коррекции возрастных изменений кожи у женщин
MY146018A (en) Method for improved breast milk feeding to reduce the risk of allergy